Clay T. Cohen, MD
- Cancer and Blood Disorders
Associate Chief, Hematology
Director, Hemophilia Treatment Center
Co-Director, Young Women's Bleeding Disorders Clinic
Assistant Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Office location:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Clay T. Cohen, MD
Personal Statement
Dr. Clay Cohen is a pediatric hematologist with clinical expertise in children and adolescents with bleeding and clotting disorders. Dr. Cohen is the Director of the Hemophilia Treatment Center at Texas Children’s Hospital where he provides care for patients with hemophilia, Von Willebrand disease, platelet function disorders, and other rare bleeding disorders. The Texas Children’s Hemophilia Treatment Center provides comprehensive care to children with bleeding disorders, including evaluation and treatment by hematology-focused physical therapists, medical geneticists, social workers, nursing coordinators, and nutritionists to provide optimal care.
Dr. Cohen is also Co-Director of the Texas Children’s Young Women’s Bleeding Disorder Clinic, a combined hematology-gynecology clinic, where he evaluates patients with heavy menstrual bleeding for an underlying bleeding disorder and offers treatment for the often-resulting iron deficiency. As young women with Von Willebrand Disease often present with heavy menstrual bleeding, he can diagnose, counsel, and treat patients and their families in this combined clinic.
Dr. Cohen is a member of the Texas Children’s hemostasis and thrombosis clinical program where he offers consultation and assistance to children with serious bleeding and clotting disorders and complications on an inpatient and outpatient setting. He also enjoys clinical education and is on the American Academy of Pediatrics (AAP) Hematology/Oncology PREP Editorial Board.
In addition to his clinical work, Dr. Cohen also performs basic science research, investigating the role of human endothelial cells in coagulation. To date he has discovered that human endothelial cells produce the active coagulation proteins necessary to activate the critical coagulation proteins, factor X and thrombin.
Dr. Cohen is a graduate of the University of Texas Medical School at Houston. He completed his residency in pediatrics at University of Alabama School of Medicine - Birmingham where he was appointed as Chief Pediatric Resident. He completed his fellowship training in pediatric hematology/oncology at Baylor College of Medicine.
He is board certified by the American Board of Pediatrics in both pediatrics and pediatric hematology/oncology.
Education
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society of Hematology (ASH) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
| Hemostasis and Thrombosis Research Society (HTRS) | Member |
| Foundation for Women & Girls with Bleeding Disorders (FWGBD) | Member |
| International Society of Thrombosis and Haemostasis (ISTH) | Member |
Board Certification
American Board of Pediatrics
Honors and awards
- 2024
-
Faculty Recognition Award, Texas Children's Cancer and Hematology Center
- 2024
-
Norton Rose Fulbright Faculty Excellence Award for Educational Materials, Baylor College of Medicine
- 2024
-
Early Career Faculty Award for Excellence in Patient Care, Baylor College of Medicine
- 2024
-
Quality Award, Texas Children's Hospital, Cancer and Hematology Center
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
